(Q35690895)

9 August 2017

1 reference

title

Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals (English)

1 reference

9 August 2017

W. Löscher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1502015

2 October 2022

language of work or name

1 reference

1 June 1992

1 reference

9 August 2017

19 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1502015

Pharmaceutisch weekblad. Scientific edition

2 October 2022

published in

1 reference

9 August 2017

14

1 reference

9 August 2017

3A

1 reference

9 August 2017

139-143

1 reference

Valproate-induced hepatic steatogenesis in rats.

9 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01962705

Comparison of the structural characteristics of the 4-aminobutyrate:2-oxoglutarate transaminases from rat and human brain, and of their affinities for certain inhibitors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01962705

Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice

21 January 2018

1 reference

12 December 2020

Trans-2-en-valproate: reevaluation of its anticonvulsant efficacy in standardized seizure models in mice, rats and dogs

1 reference

12 December 2020

Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture

1 reference

12 December 2020

Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats

1 reference

12 December 2020

Effect of valproic acid on serotonin metabolism

1 reference

12 December 2020

Alterations in CSF GABA levels and seizure susceptibility developing during repeated administration of pentetrazole in dogs. Effects of ?-acetylenic GABA, valproic acid and phenobarbital

1 reference

12 December 2020

Anticonvulsant activity and embryotoxicity of valproic acid

1 reference

12 December 2020

Is amygdala kindling in rats a model for drug-resistant partial epilepsy?

1 reference

12 December 2020

Monoamine and GABA metabolism and the anticonvulsant action of DI-n-propylacetate and ethanolamine-O-sulphate

1 reference

12 December 2020

Valproic acid and active unsaturated metabolite (2-en): transfer to mouse liver following human therapeutic doses

1 reference

12 December 2020

Comparative transfer of valproic acid and of an active metabolite into brain and liver: possible pharmacological and toxicological consequences.

1 reference

12 December 2020

Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy

1 reference

12 December 2020

Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture.

1 reference

12 December 2020

Anticonvulsant activity of metabolites of valproic acid

1 reference

12 December 2020

Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse

1 reference

12 December 2020

Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.

1 reference

12 December 2020

Valproic Acid and Metabolites: Pharmacological and Toxicological Studies

1 reference

12 December 2020

Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse

1 reference

12 December 2020

The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies

1 reference

12 December 2020

Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings.

1 reference

12 December 2020

Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice

1 reference

12 December 2020

Marked increase in anticonvulsant activity but decrease in wet-dog shake behaviour during short-term treatment of amygdala-kindled rats with valproic acid

1 reference

12 December 2020

Effect of propyl-2-pentene-2-oic acid on GABA levels in different regions of mouse brain

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01962705

1 reference

9 August 2017

1 reference